# QALSODY
> **NDA215887** · New Drug Application · Sponsor: BIOGEN MA · Approved 2023-04-25
## Drug
- **FDA Application Number:** NDA215887
- **Application type:** New Drug Application
- **Brand name:** QALSODY
- **Generic name:** TOFERSEN
- **Active ingredients:** TOFERSEN
- **Dosage form:** SOLUTION
- **Route:** INTRATHECAL
- **Marketing status:** Prescription
- **Sponsor:** BIOGEN MA
- **Manufacturer:** Biogen Inc.
- **First approval:** 2023-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215887)
---
*MORVS · CC0 1.0*